Skip to content

Comparison of postoperative analgesia with two different doses of intrathecal nalbuphine; a prospective, randomized, double-blind control study

Comparison of postoperative analgesia with two different doses of intrathecal nalbuphine; a prospective, randomized, double-blind control study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250507004
Enrollment
120
Registered
2025-05-07
Start date
2024-02-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parturients,cesarean section nalbuphine, cesarean section, Intrathecal nalbuphine, analgesia

Interventions

intrathecal hyperbaric 0.5% bupivacaine 2.0 ml , intrathecal hyperbaric 0.5% bupivacaine 2.0 ml nalbuphine 1.6 mg ,intrathecal hyperbaric 0.5% bupivacaine 2.0 ml nalbuphine 2.0 mg
bupivacaine, nalbuphine 1, nalbuphine 2

Sponsors

None listed

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.parturients with American Society of Anesthesiologists (ASA) physical status II who underwent elective uncomplicated or low-risk lower-segment cesarean section, 2.full-term singleton pregnant women, 3.scheduled for elective Caesarean delivery,

Exclusion criteria

Exclusion criteria: 1.parturients on anticoagulants, 2.infection at the site of lumbar puncture 3.The withdrawal criteria is inadequate anesthetic level and sedative drug usage.

Design outcomes

Primary

MeasureTime frame
Onset of sensory blockade post receive anesthetic durg test sensory with temperature

Secondary

MeasureTime frame
Onset of motor blockade before start incisional time ,Time for two-segment regression post surgery complete in PACU test from sensation,Total duration of motor blockade end of anesthitic durg start recive anesthetic durg

Countries

Thailand

Contacts

Public Contactsittiporn Deetayard

intrathecal hyperbaric

Doxterer@hotmail.com032719600

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026